A Retrospective Study of the Safety and Efficacy of Endoscopic Radiofrequency Therapy Under Direct Vision in 59 Patients with Gastroesophageal Reflux Disease from 2 Centers in Beijing, China Using the Gastroesophageal Reflux Disease Questionnaire

Di Lu; Chun Shan Bi; Xue Wei; Bao Na Guo; Ying Xin Gao; Jing Chen; Jie Qian; Zi Hao Guo; Yan Bin Wang; Li Li; Chuan Zhang; Jian Yu Hao; Yan Gao

doi:10.12659/MSM.933848

23 February 2022 : Clinical Research

A Retrospective Study of the Safety and Efficacy of Endoscopic Radiofrequency Therapy Under Direct Vision in 59 Patients with Gastroesophageal Reflux Disease from 2 Centers in Beijing, China Using the Gastroesophageal Reflux Disease Questionnaire

Di Lu^1ABCDEFG, Chun Shan Bi^2ABCE, Xue Wei^1BCDEF, Bao Na Guo^2BC, Ying Xin Gao^1BG, Jing Chen^2B, Jie Qian^1BG, Zi Hao Guo^2B, Yan Bin Wang^1B, Li Li^2B, Chuan Zhang^2A, Jian Yu Hao^1AG*, Yan Gao^1ABD

DOI: 10.12659/MSM.933848

Med Sci Monit 2022; 28:e933848

Authors information Article notes Copyright and License information

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 3 Comparison of PPIs* usage reduction between the 2 groups.

Timing of RF**	Direct vision (N=27)	Non-direct vision (N=29)	P value
Before RF^**	0 (0)	0 (0)	–
3 months after RF^**	22 (81.5%)	22 (75.9%)	0.609
6 months after RF^**	24 (88.9%)	28 (96.6%)	0.343
12 months after RF (N=45)^**	20 (95.2%) (N=21)	23 (95.8%) (N=24)	1.000
^* PPIs denotes proton pump inhibitors; ^** RF denotes radiofrequency.

Back to the Article

A Retrospective Study of the Safety and Efficacy of Endoscopic Radiofrequency Therapy Under Direct Vision in 59 Patients with Gastroesophageal Reflux Disease from 2 Centers in Beijing, China Using the Gastroesophageal Reflux Disease Questionnaire

Your Privacy